Dianthus Therapeutics Banner

Press Releases

DIANTHUS THERAPEUTICS ANNOUNCES FDA CLEARANCE TO INITIATE PHASE 2 TRIAL OF DNTH103 IN MULTIFOCAL MOTOR NEUROPATHY (MMN)